⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TCRX News
TScan Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
TCRX
Form 8-K
sec.gov
TCRX
TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors
globenewswire.com
TCRX
Kalohexis Appoints Garry Menzel, Ph.D., to Board of Directors
prnewswire.com
BTAI
REGN
STOK
TCRX
Form 8-K
sec.gov
TCRX
Form 8-K
sec.gov
TCRX
TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
TCRX
TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies
globenewswire.com
TCRX
Hyperscale Data Centers Lead Growth in Global Cable Market
globenewswire.com
AMZN
MSFT
GOOGL
META
GLW
TCRX
BDC
TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
globenewswire.com
TCRX